Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023

Amidst a tenuous market, increasing government drug pricing scrutiny and patent cliffs, the top 20 global biopharma companies experienced vastly different shifts in market capitalization in 2023. A report from data analytics firm GlobalData Tuesday reveals an aggregated 1.5% upturn to $3.67 trillion compared to 2022.